Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer

Status:
Completed

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients with Prostate Cancer.

Phase 2

Ferring Pharmaceuticals